These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12146812)

  • 41. The impact of exposure to Internet-based information about the Rorschach and the MMPI-2 on psychiatric outpatients' ability to simulate mentally healthy test performance.
    Hartmann E; Hartmann T
    J Pers Assess; 2014; 96(4):432-44. PubMed ID: 24528223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interpretation of a full-information item-level factor analysis of the MMPI-2: normative sampling and nonpathognomonic descriptors.
    Leonelli BT; Chang CH; Bock RD; Schilling SG
    J Pers Assess; 2000 Jun; 74(3):400-22. PubMed ID: 10900568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The validity and clinical utility of the MMPI-2 Malingering Depression scale.
    Bagby RM; Marshall MB; Bacchiochi JR
    J Pers Assess; 2005 Dec; 85(3):304-11. PubMed ID: 16318569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The MMPI-2 Clinical Scales and Restructured Clinical (RC) Scales: comparative psychometric properties and relative diagnostic efficiency in young adults.
    Osberg TM; Haseley EN; Kamas MM
    J Pers Assess; 2008 Jan; 90(1):81-92. PubMed ID: 18444099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of NEO-PI-R research validity scales for discriminating analog malingering and genuine psychopathology.
    Berry DT; Bagby RM; Smerz J; Rinaldo JC; Caldwell-Andrews A; Baer RA
    J Pers Assess; 2001 Jun; 76(3):496-516. PubMed ID: 11499461
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new perspective on gender orientation measurement with the MMPI-2: development of the Masculine-Feminine Pathology Scale.
    McGrath RE; Sapareto E; Pogge DL
    J Pers Assess; 1998 Jun; 70(3):551-63. PubMed ID: 9760743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MMPI-2 at the crossroads: aging technology or radical retrofitting?
    Rogers R; Sewell KW
    J Pers Assess; 2006 Oct; 87(2):175-8. PubMed ID: 16972820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of MMPI-2 and PAI validity indicators to detect feigned depression and PTSD symptom reporting.
    Lange RT; Sullivan KA; Scott C
    Psychiatry Res; 2010 Apr; 176(2-3):229-35. PubMed ID: 20207423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Graying of the critical items: effects of aging on responding to MMPI-2 critical items.
    Aaronson AL; Dent OB; Webb JT; Kline CD
    J Pers Assess; 1996 Feb; 66(1):169-76. PubMed ID: 8576830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of the usefulness of the MMPI-2 F(p) scale.
    Archer RP; Handel RW; Greene RL; Baer RA; Elkins DE
    J Pers Assess; 2001 Apr; 76(2):282-95. PubMed ID: 11393461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An examination of three sets of MMPI-2 personality disorder scales.
    Jones A
    J Pers Disord; 2005 Aug; 19(4):370-85. PubMed ID: 16178680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Validation of the MMPI-2 Low Self-Esteem Content Scale.
    Brems C; Lloyd P
    J Pers Assess; 1995 Dec; 65(3):550-6. PubMed ID: 8609587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MMPI response-set characteristics among adolescents.
    Archer RP; Gordon RA; Kirchner FH
    J Pers Assess; 1987; 51(4):506-16. PubMed ID: 3681637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Examining the impact of unscorable item responses on the validity and interpretability of MMPI-2/MMPI-2-RF Restructured Clinical (RC) Scale scores.
    Dragon WR; Ben-Porath YS; Handel RW
    Assessment; 2012 Mar; 19(1):101-13. PubMed ID: 21835886
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Further evidence on the validity of the MMPI-2 Restructured Clinical (RC) Scales: addressing questions raised by Rogers, Sewell, Harrison, and Jordan and Nichols.
    Tellegen A; Ben-Porath YS; Sellbom M; Arbisi PA; McNulty JL; Graham JR
    J Pers Assess; 2006 Oct; 87(2):148-71. PubMed ID: 16972818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability of MMPI scale scores within four codetypes across forty years.
    Greene RL
    J Pers Assess; 1990; 55(1-2):1-6. PubMed ID: 2231234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spirituality and the MMPI-2.
    MacDonald DA; Holland D
    J Clin Psychol; 2003 Apr; 59(4):399-410. PubMed ID: 12652633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detecting fake-good and fake-bad MMPI-2 profiles.
    Graham JR; Watts D; Timbrook RE
    J Pers Assess; 1991 Oct; 57(2):264-77. PubMed ID: 1955975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bridging the divide: comments on the Restructured Clinical Scales of the MMPI-2.
    Simms LJ
    J Pers Assess; 2006 Oct; 87(2):211-6. PubMed ID: 16972825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.